These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8780301)

  • 21. Tranylcypromine isomers in depressed outpatients: effects on depression, monoamine oxidase inhibition and tyramine pressor response.
    Van de Merwe TJ; Pare CM; Glover V; Sandler M
    Mod Probl Pharmacopsychiatry; 1983; 19():189-202. PubMed ID: 6346066
    [No Abstract]   [Full Text] [Related]  

  • 22. Do antihypertensives make tranylcypromine safer? Three case reports.
    Taylor BP; Quitkin FM; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2005 May; 66(5):657-8. PubMed ID: 15889959
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open trial of MAO inhibitors in bulimia.
    Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
    J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of monoamine oxidase inhibitors in the treatment of elderly, depressed patients.
    Jenike MA
    J Am Geriatr Soc; 1984 Aug; 32(8):571-5. PubMed ID: 6747167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary on STAR*D: a summary and UK perspective.
    Cowen PJ
    J Psychopharmacol; 2009 Aug; 23(6):618-9; discussion 622-4. PubMed ID: 19395431
    [No Abstract]   [Full Text] [Related]  

  • 29. Spontaneous hypertensive reactions with monoamine oxidase inhibitors.
    Lavin MR; Mendelowitz A; Kronig MH
    Biol Psychiatry; 1993 Aug; 34(3):146-51. PubMed ID: 8399806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scaling down.
    Seeman MV
    Am J Psychiatry; 2003 May; 160(5):847-9. PubMed ID: 12727685
    [No Abstract]   [Full Text] [Related]  

  • 31. Tranylcypromine in mind (Part I): Review of pharmacology.
    Ulrich S; Ricken R; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroconvulsive therapy and monoamine oxidase inhibitors.
    Ribeiro RB; Rosa MA; Rigonatti SP
    Braz J Psychiatry; 2008 Dec; 30(4):406-7. PubMed ID: 19142425
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation.
    Hamani C; Giacobbe P; Diwan M; Balbino ES; Tong J; Bridgman A; Lipsman N; Lozano AM; Kennedy SH; Nobrega JN
    Am J Psychiatry; 2012 Dec; 169(12):1320-1. PubMed ID: 23212066
    [No Abstract]   [Full Text] [Related]  

  • 34. N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression.
    Carvalho AF; Macêdo DS; Goulia P; Hyphantis TN
    J Clin Psychopharmacol; 2013 Oct; 33(5):719-20. PubMed ID: 23899640
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone plus a monoamine oxidase inhibitor for agitated depression crisis.
    Welner M
    J Clin Psychopharmacol; 1996 Dec; 16(6):460-1. PubMed ID: 8959474
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: a review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromine.
    Krings-Ernst I; Ulrich S; Adli M
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):763-70. PubMed ID: 23993253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tranylcypromine in recurrent brief depression: two case reports.
    Joffe RT
    Int Clin Psychopharmacol; 1996 Dec; 11(4):287-8. PubMed ID: 9031997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K; Grohmann R; Hippius H; Rüther E
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.